Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3144 results

Sort By:

Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

Study ID: NCT05202288
Start Date: 2027-01
End Date: 2027-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

132

Intervention / Treatment

Ervebo

Models

Sponsor

ANRS, Emerging Infectious Diseases

Source: clinicaltrials.gov

Share:
Add to list

Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial)

Study ID: NCT07454980
Start Date: 2026-05
End Date: 2038-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

680

Intervention / Treatment

TTVI with LuX-Valve Plus System

TTVI with EVOQUE

Sponsor

Jenscare Innovation Inc.

Source: clinicaltrials.gov

Share:
Add to list

Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma

Study ID: NCT07285239
Start Date: 2026-05
End Date: 2034-04
Study Type

Interventional

Study Phase

Phase3

No. of Participants

500

Intervention / Treatment

Arm A: Belantamab Mafodotin

Arm B: Daratumumab Hyaluronidase

Bortezomib

Lenalidomide

Dexamethasone

Sponsor

PrECOG, LLC.

Source: clinicaltrials.gov

Share:
Add to list

PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer

Study ID: NCT07291557
Start Date: 2026-05
End Date: 2036-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

250

Intervention / Treatment

Prostate Only Radiation Therapy (PORT)

Prostate + Whole Pelvis Radiation Therapy (P-WPRT)

Sponsor

AHS Cancer Control Alberta

Source: clinicaltrials.gov

Share:
Add to list

A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients

Study ID: NCT07404202
Start Date: 2026-03-12
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2100

Intervention / Treatment
Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Optimizing Implementation of the Intensive Diabetes Prevention Program

Study ID: NCT07412912
Start Date: 2026-06-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

170

Intervention / Treatment

Standard IDPP

Optimized IDPP

Sponsor

The Hong Kong Polytechnic University

Source: clinicaltrials.gov

Share:
Add to list

Improv Music Therapy for Older Adults

Study ID: NCT07419022
Start Date: 2026-12
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Clinical Improvisation

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Crown Removal in Non-Surgical Peri-Implantitis Therapy: A Randomized Trial

Study ID: NCT07391202
Start Date: 2026-04-01
End Date: 2027-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment

Non-Surgical Peri-Implant Therapy without Crown

Non-Surgical Peri-Implant Therapy with Crown

Sponsor

G. d'Annunzio University

Source: clinicaltrials.gov

Share:
Add to list

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Study ID: NCT07420439
Start Date: 2026-05-15
End Date: 2028-11-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

108

Intervention / Treatment

Paclitaxel

bevacizumab

Carboplatin

Pemetrexed

Vinorelbine

Nivolumab

Pembrolizumab

Gemcitabine

Sponsor

French-speaking Thoracic Cancerology Intergroup

Source: clinicaltrials.gov

Share:
Add to list

GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)

Study ID: NCT05303701
Start Date: 2027-07
End Date: 2031-07
Study Type

Interventional

Study Phase

Phase3

No. of Participants

750

Intervention / Treatment

GV1001 Placebo

GV1001 1.12mg

Sponsor

Samsung Pharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list